Article
Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease.
Inflammatory bowel diseases - 1 Mar 2011
Lakatos Peter Laszlo, Kiss Lajos Sandor, Palatka Karoly, Altorjay Istvan, Antal-Szalmas Peter, Palyu Eszter, Udvardy Miklos, Molnar Tamas, Farkas Klaudia, Veres Gabor, Harsfalvi Jolan, Papp Janos, Papp Maria
Abstract excerpt
BACKGROUND: In inflammatory bowel disease (IBD), enhanced inflammatory activity in the gut is thought to increase the risk of bacterial translocation and endotoxemia. In the present study we investigated the association between serum level of lipopolysaccharide-binding protein (LBP), soluble CD14...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
